financetom
Business
financetom
/
Business
/
Market Chatter: Pfizer Exploring Sale of Hospital Drugs Unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Pfizer Exploring Sale of Hospital Drugs Unit
Nov 12, 2024 11:01 AM

10:20 AM EST, 11/12/2024 (MT Newswires) -- Pfizer ( PFE ) is exploring a sale of its hospital drugs unit, as it looks to divest non-core assets amid pressure from activist investor Starboard Value, Reuters reported, citing three people familiar with the matter.

Pfizer ( PFE ) did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 26.32, Change: +0.08, Percent Change: +0.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices
Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices
Oct 20, 2025
07:40 AM EDT, 10/20/2025 (MT Newswires) -- Apple ( AAPL ) is facing a complaint filed with China's market regulator alleging abuse of its market position by restricting app distribution and payments to its own iOS platform on iPhones and iPads, Reuters reported Monday. The report cited a lawyer as saying that a filing to China's State Administration for Market...
Ideaya Says Darovasertib With Crizotinib Shows Median Overall Survival of 21.1 Months in Eye Cancer Trial
Ideaya Says Darovasertib With Crizotinib Shows Median Overall Survival of 21.1 Months in Eye Cancer Trial
Oct 20, 2025
07:16 AM EDT, 10/20/2025 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said Monday that a phase 1/2 trial evaluating darovasertib in combination with Pfizer's crizotinib as a first-line treatment for patients with metastatic uveal melanoma showed a median overall survival of 21.1 months. The investigational combination therapy also demonstrated a median progression free survival of seven months, a confirmed...
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment
Oct 20, 2025
Overview * STAAR Surgical ( STAA ) Q3 preliminary net sales rise 6.9% yr/yr, beating analyst expectations * Sales growth driven by recognition of deferred China shipment * Lower new orders from China due to leaner inventory management Outlook * STAAR Surgical ( STAA ) did not provide specific future guidance in its press release Result Drivers * DEFERRED CHINA...
Alto Neuroscience Signs $50 Million PIPE Financing Deal
Alto Neuroscience Signs $50 Million PIPE Financing Deal
Oct 20, 2025
07:42 AM EDT, 10/20/2025 (MT Newswires) -- Alto Neuroscience ( ANRO ) said Monday that it signed a securities purchase agreement with institutional and accredited investors for a $50 million private investment in public equity, or PIPE, financing. The company is selling about 3.8 million common shares at $5.914 each and pre-funded warrants to purchase up to about 4.6 million...
Copyright 2023-2026 - www.financetom.com All Rights Reserved